%0 Journal Article %A Hongquan Li %A Ethan Li %A Deepak Krishnamurthy %A Patrick Kolbay %A Beca Chacin %A Soeren Hoehne %A Jim Cybulski %A Lara Brewer %A Tomasz Petelenz %A Joseph Orr %A Derek Sakata %A Thomas Clardy %A Kai Kuck %A Manu Prakash %T Utah-Stanford Ventilator (Vent4US): Developing a rapidly scalable ventilator for COVID-19 patients with ARDS %D 2020 %R 10.1101/2020.04.18.20070367 %J medRxiv %P 2020.04.18.20070367 %X We describe a minimum, rapidly scalable ventilator designed for COVID-19 patients with ARDS. Our design philosophy is not only to try to address potential ventilator shortages, but also to account for uncertainties in the supply chains of parts commonly used in traditional ventilators. To do so we employ a modular design approach and broadly explore taking advantage of parts from non-traditional supply chains. In our current prototype, we demonstrate volume control with assist control on a test lung and present a linear actuator-driven pinch valve-based implementation for both pressure control and volume control with decelerating inspiratory flow. We estimate the component cost of the system to be around $500. We publish our draft design documents and current implementation which is open and accessible in the hope that broadening the community globally will accelerate arriving at a solution and that peer review will improve the final design.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe thank Schmidt Futures, Moore Foundation, CZI BioHub and HHMI-Gates Foundation for financial support to the Prakash Lab.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is included in the manuscript. All code developed for this work is openly accessible at out GitHub repository at https://github.com/vent4us/vent-devhttps://github.com/vent4us/vent-devhttp://www.vent4us.org %U https://www.medrxiv.org/content/medrxiv/early/2020/04/21/2020.04.18.20070367.full.pdf